title: [After bypass surgery nearly all lipids are in the normal range. However, Lp(a) is too high, what can be done?].
authors: Medizinische Klinik II-Grosshadern, Klinikum der Universität München, Marchioninistrasse 15, D-81377 München.
authors: Klaus G
authors: KG
authors: Parhofer
mesh_terms: D001384:Azetidines / Q000627:therapeutic use; D002784:Cholesterol / Q000097:blood*; D001026:Coronary Artery Bypass; D003324:Coronary Artery Disease / Q000097:blood* / Q000601:surgery*; D004359:Drug Therapy, Combination; D000069438:Ezetimibe; D005229:Fatty Acids, Monounsaturated / Q000627:therapeutic use; D000077340:Fluvastatin; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood* / Q000188:drug therapy; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D007211:Indoles / Q000627:therapeutic use; D017270:Lipoprotein(a) / Q000097:blood*; D008297:Male; D011183:Postoperative Complications / Q000097:blood*; D011379:Prognosis; D012016:Reference Values; D012307:Risk Factors; D055502:Secondary Prevention; D016896:Treatment Outcome
chemical_list: D001384:Azetidines; D005229:Fatty Acids, Monounsaturated; D000960:Hypolipidemic Agents; D007211:Indoles; D017270:Lipoprotein(a); D000077340:Fluvastatin; D002784:Cholesterol; D000069438:Ezetimibe